Dashboard
Manage Tickers

GTLBGitlab Inc.

Nasdaq about.gitlab.com


$ 55.48 $ -0.55 (-0.98 %)    

Friday, 26-Apr-2024 15:59:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 55.46
$ 56.46
$ 0.00 x 0
$ 0.00 x 0
$ 54.98 - $ 56.61
$ 26.24 - $ 78.53
1,675,171
na
8.56B
$ 2.48
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-25-2024 01-31-2024 10-K
2 12-05-2023 10-31-2023 10-Q
3 09-05-2023 07-31-2023 10-Q
4 06-05-2023 04-30-2023 10-Q
5 03-30-2023 01-31-2023 10-K
6 12-06-2022 10-31-2022 10-Q
7 09-06-2022 07-31-2022 10-Q
8 06-06-2022 04-30-2022 10-Q
9 04-08-2022 01-31-2022 10-K
10 12-07-2021 10-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

how-is-the-market-feeling-about-gitlab
How Is The Market Feeling About GitLab?
04/19/2024 13:45:15

raymond-james-upgrades-gitlab-to-outperform-announces-70-price-target
Raymond James Upgrades GitLab to Outperfor...
04/12/2024 09:42:08

Raymond James analyst Adam Tindle upgrades GitLab (NASDAQ:GTLB) from Market Perform to Outperform and announces $70 price ta...

wells-fargo-initiates-coverage-on-gitlab-with-overweight-rating-announces-price-target-of-70
Wells Fargo Initiates Coverage On GitLab w...
04/09/2024 13:31:08

Wells Fargo analyst Michael Turrin initiates coverage on GitLab (NASDAQ:GTLB) with a Overweight rating and announces Price T...

gitlab-inc-showcases-strong-fy-24-performance-and-strategic-ai-investments-in-conference-call
GitLab Inc. Showcases Strong FY '24 Perfor...
04/05/2024 18:20:04

In a recent conference call hosted by Truist Securities, GitLab Inc. (NasdaqGS: GTLB) revealed a robust performance for the fis...

jim-cramer-nothing-terrific-about-gitlab-but-rocket-time-to-ka-ching-ka-ching
Jim Cramer: 'Nothing Terrific' About GitLa...
04/05/2024 12:55:46

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he didn’t like the last quarter of GitLab Inc. (NASDAQ: GTLB)....

looking-into-gitlabs-recent-short-interest
Looking Into GitLab's Recent Short Interest
04/02/2024 14:15:26

critical-insights-from-gitlab-analyst-ratings-what-you-need-to-know
Critical Insights From GitLab Analyst Rati...
04/01/2024 19:01:01

truist-securities-reiterates-buy-on-gitlab-maintains-80-price-target
Truist Securities Reiterates Buy on GitLab...
04/01/2024 12:50:15

Truist Securities analyst Joel Fishbein reiterates GitLab (NASDAQ:GTLB) with a Buy and maintains $80 price target.

gitlab-acquires-oxeye-terms-not-disclosed
GitLab Acquires Oxeye, Terms Not Disclosed
03/20/2024 20:47:21

gitlab-is-a-gen-ai-beneficiary-with-growth-upside-says-bullish-analyst-heres-why
GitLab Is A Gen AI Beneficiary With Growth...
03/19/2024 20:14:15

Earlier this month, GitLab Inc (NASDAQ: GTLB) reported upbeat fourth-quarter results, but its shares came under pressure on mix...

keybanc-initiates-coverage-on-gitlab-with-overweight-rating-announces-price-target-of-70
Keybanc Initiates Coverage On GitLab with ...
03/19/2024 09:24:54

Keybanc analyst Jason Celino initiates coverage on GitLab (NASDAQ:GTLB) with a Overweight rating and announces Price Target ...

clover-health-stock-is-up-after-q4-results
Clover Health Stock Is Up After Q4 Results
03/12/2024 20:43:21

Clover Health Investments reported quarterly sales of $510.3 million which beat the analyst consensus estimate of $480.25 milli...

looking-into-gitlabs-recent-short-interest
Looking Into GitLab's Recent Short Interest
03/08/2024 19:15:27

a-closer-look-at-16-analyst-recommendations-for-gitlab
A Closer Look at 16 Analyst Recommendation...
03/06/2024 13:01:38

bernstein-maintains-outperform-on-gitlab-lowers-price-target-to-74
Bernstein Maintains Outperform on GitLab, ...
03/06/2024 12:10:33

Bernstein analyst Peter Weed maintains GitLab (NASDAQ:GTLB) with a Outperform and lowers the price target from $76 to $74.

wolfe-research-upgrades-gitlab-to-outperform-announces-75-price-target
Wolfe Research Upgrades GitLab to Outperfo...
03/06/2024 10:23:21

Wolfe Research analyst Allan Verkhovski upgrades GitLab (NASDAQ:GTLB) from Peer Perform to Outperform and announces $75 pri...

fear--greed-index-moves-to-greed-zone-dow-dips-over-400-points
Fear & Greed Index Moves To 'Greed' Zone; ...
03/06/2024 07:29:16

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, with the index moving to the "Greed...

whats-going-on-with-gitlab-stock-tuesday
What's Going On With GitLab Stock Tuesday?
03/05/2024 19:36:58

RBC analyst reiterates GitLab as Outperform with $80 price target. Q4 revenue beat estimates but stock fell on mixed 2025 guida...

bears-prowl-wall-street-as-magnificent-7-tumble-bitcoin-sinks-after-record-high-whats-driving-markets-tuesday
Bears Prowl Wall Street As Magnificent 7 T...
03/05/2024 19:01:09

Wall Street indices in the red as tech stocks plunge. Tesla down 4%, Apple down 2.7%. ISM Services PMI lower than expected. Bit...

why-sophia-genetics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why SOPHiA GENETICS Shares Are Trading Low...
03/05/2024 18:11:47

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expect...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION